Antiretroviral activity of naloxone and naltrexone.
Mahayni
H
H
Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD 20852.
Minor
J R
JR
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology* / Q000627:therapeutic use; D009271:Naltrexone / Q000494:pharmacology* / Q000627:therapeutic use
D000998:Antiviral Agents; D009270:Naloxone; D009271:Naltrexone